Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection

Sam Hopkins(Scynexis (United States)), Philippe Gallay(Scripps Research Institute)
Viruses
October 29, 2012
Cited by 53


Related Papers